BioCentury | Jan 13, 2018
Finance

Choosy investors

...BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. 12/9/16 $23M Ph I Orient Pharma Co. Ltd....
BioCentury | Oct 6, 2017
Finance

High as a Kite

...BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. 12/9/16 $23M Ph I Orient Pharma Co. Ltd....
BioCentury | Jul 7, 2017
Finance

Generalists needed

...BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. 12/9/16 $23M Ph I Orient Pharma Co. Ltd....
BioCentury | Apr 7, 2017
Finance

Taking notice

...Biomed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. 12/9/16 $23M Ph I Orient Pharma Co. Ltd....
BioCentury | Jan 6, 2017
Finance

Good riddance

...12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. (NYSE-M) 12/9/16 Up to $36M Ph I Orient Pharma Co. Ltd....
BioCentury | Dec 9, 2016
Financial News

Orient Pharma proposes IPO

...other requirements. Orient Pharma began trading as an emerging stock in 2012. Orient Pharma Co. Ltd. (TPEx-E:4166), Taipei, Taiwan Alicia Parker Orient Pharma Co. Ltd....
BioCentury | Apr 11, 2011
Finance

Playing tax arbitrage

Cephalon Inc. rejected Valeant Pharmaceuticals International Inc. 's hostile bid last week as too low, but the advantages Valeant's tax structure provides make it hard to see how Cephalon can compete for the affections of...
BioCentury | Aug 24, 2009
Company News

Durect, Orient deal

...Durect granted Orient's Orient Pharma Co. Ltd. subsidiary rights in selected Asian and South Pacific countries to develop and...
...deficit hyperactivity disorder (ADHD). Durect will be responsible for formulation and clinical study design, and Orient Pharma...
...fund the program. The companies will collaborate on development through a Phase II trial, and Orient Pharma...
BioCentury | Sep 29, 2008
Company News

Summit, Orient Europharma deal

...Orient Europharma's Orient Pharma subsidiary received exclusive rights to develop and commercialize Summit's SMT D001 in the...
Items per page:
1 - 9 of 9
BioCentury | Jan 13, 2018
Finance

Choosy investors

...BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. 12/9/16 $23M Ph I Orient Pharma Co. Ltd....
BioCentury | Oct 6, 2017
Finance

High as a Kite

...BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. 12/9/16 $23M Ph I Orient Pharma Co. Ltd....
BioCentury | Jul 7, 2017
Finance

Generalists needed

...BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. 12/9/16 $23M Ph I Orient Pharma Co. Ltd....
BioCentury | Apr 7, 2017
Finance

Taking notice

...Biomed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. 12/9/16 $23M Ph I Orient Pharma Co. Ltd....
BioCentury | Jan 6, 2017
Finance

Good riddance

...12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc. (NYSE-M) 12/9/16 Up to $36M Ph I Orient Pharma Co. Ltd....
BioCentury | Dec 9, 2016
Financial News

Orient Pharma proposes IPO

...other requirements. Orient Pharma began trading as an emerging stock in 2012. Orient Pharma Co. Ltd. (TPEx-E:4166), Taipei, Taiwan Alicia Parker Orient Pharma Co. Ltd....
BioCentury | Apr 11, 2011
Finance

Playing tax arbitrage

Cephalon Inc. rejected Valeant Pharmaceuticals International Inc. 's hostile bid last week as too low, but the advantages Valeant's tax structure provides make it hard to see how Cephalon can compete for the affections of...
BioCentury | Aug 24, 2009
Company News

Durect, Orient deal

...Durect granted Orient's Orient Pharma Co. Ltd. subsidiary rights in selected Asian and South Pacific countries to develop and...
...deficit hyperactivity disorder (ADHD). Durect will be responsible for formulation and clinical study design, and Orient Pharma...
...fund the program. The companies will collaborate on development through a Phase II trial, and Orient Pharma...
BioCentury | Sep 29, 2008
Company News

Summit, Orient Europharma deal

...Orient Europharma's Orient Pharma subsidiary received exclusive rights to develop and commercialize Summit's SMT D001 in the...
Items per page:
1 - 9 of 9